Peiwen Fei Associate Professor working at the University of Hawaii Cancer Center, Honolulu,USA. |
||
Biography | ||
I am currently an associate professor working at the University of Hawaii Cancer Center, Honolulu, Hawaii. I obtained my PhD degree in Department of Pathology and Cell Biology at Thomas Jefferson University, Philadelphia in 2001. I started my own independent research programs at Mayo Clinic, Rochester, Minnesota in 2005 after finishing the fellowship training at University of Pennsylvania/the Howard Hughes Medical Institute (HHMI) and National Institutes of Health (NIH). Our research interests focus on how tumor suppressors function and what can be learned from cancer susceptibility syndromes, such as Fanconi Anemia and Li-Fraumeni syndrome. For a decade, our work has centered on two tumor suppressor-signaling pathways, the p53 and Fanconi Anemia -BRCA signaling pathways, and their implications in tumor development and cancer treatment. | ||
Research Interest | ||
how tumor suppressors function and what can be learned from cancer susceptibility syndromes, such as Fanconi Anemia and Li-Fraumeni syndrome | ||
Global Experts in the subject | ||
Abhishek Bhatt | Amar B. Singh | Asuthkar Swapna |
Chaitali Sen | Crystal Hann | Dianqing Sun |
Geng-Xian Shi | Guoxiang Xie | Haitao Wu |
Ken He Young | Kevin Cassel | Mufaddal Najmuddin |
Punita Dhawan | Saverio Gentile | Weisi Yan |
Yan Ni |
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2019 All rights reserved. iMedPub LTD Last revised : February 19, 2019